Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2020.01.07

Discovering the joys of Chemistry

Discovering the joys of Chemistry

An eager and curious group of high school students from Sanskriti School recently visited the Sai Life Sciences R&D centre in Hyderabad to get a first-hand feel of the facilities, interact with the scientists and understand the work they do.

As a company committed to building a better ecosystem of scientific talent, Sai Life Sciences regularly hosts student groups from various educational institutions across the state. The objective of these excursions is to inspire young minds about the possibilities of chemistry and its role in discovering new lifesaving medicines.

Speaking about her visit, a student said, “This has been an eye-opening experience! It helped me visualize what we learn at school, while also getting exposed to many things that we don’t normally learn about!”
Educational tours like these help students get an exposure to the pharmaceutical industry, learn about the various functions in pharmaceutical companies, and spark ideas for potential future career choices.

“Children showed a lot of interest in the analysis and instrumentation. They were eager to know which reactions were running in the vessels and were curious to how we confirm that a reaction is complete” said Ganesh Yaddanapudi, Senior Director, Process R&D, about his interaction with the students.

The Sai team shared their personal experiences on choosing chemistry as profession, and enthusiastically answered many thought-provoking questions that students asked during the tour.

“The chemical industry is not only about pipettes and coloured solutions, as we commonly perceive it to be. We got to know many new things, thanks to our visit today.” said one of the students.

Share article

More News

2024.02.08

Sai Life Sciences releases its Sustainability Report 2023

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability […]
Read more

2024.02.01

Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations

To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), has expanded its DMPK capabilities. The expansion comprises the addition of 25,000 sq. ft. of state-of-the-art labs equipped with cutting-edge instrumentation enabling high-end automation. Complementing the expansion has been […]
Read more

2024.01.24

Sai Life Sciences strengthens discovery leadership

Sai Life Sciences, a leading global contract research, development, and manufacturing organization, announces the addition of two seasoned professionals to its leadership team. Dr Atul Tiwari joins as Vice President – Discovery Strategy & Business, while Dr Santosh Kulkarni takes on the role of Vice President – Medicinal Chemistry. Their wealth of experience promises to […]
Read more

2023.12.21

Sai Life Sciences wins Gold in Brandon Hall Group’s Excellence in Technology Awards

Sai Life Sciences won Gold in Brandon Hall Group’s Excellence in Technology Awards in the ‘Best Advance in Content Authoring Technology’ category. Sai Life Sciences was recognized for the use of UL Create Tool, an easy-to-use, cloud-based authoring tool from UL Solutions, for making the learning process seamless and effective for all. The company utilized […]
Read more

2023.08.21

Sai Life Silver Jubilee year

Sai Life Sciences enters its Silver Jubilee year; surpasses vision of 25 commercial molecules by 2025

Sai Life Sciences entered its Silver Jubilee year with aplomb, surpassing its vision of supporting global innovator partners in bringing 25 new medicines to market by 2025. The company crossed this milestone two years ahead of schedule and is poised to sustain this momentum on the back of a strong portfolio of molecules at various […]
Read more